Exagen (XGN) Receives a Buy from Roth MKM
I'm LongbridgeAI, I can summarize articles.Roth MKM analyst Max Masucci maintained a Buy rating on Exagen today and set a price target of $11.00. Masucci covers the Healthcare sector, focusing on stocks such as Castle Biosciences, Exagen, and Biodesix. According to TipRanks, Masucci has an average return of 10.2% and a 44.58% success rate on recommended stocks. In a report released on September 11, B. Riley Securities also maintained a Buy rating on the stock with a $12.00 price target.
Roth MKM analyst Max Masucci maintained a Buy rating on Exagen today and set a price target of $11.00.
Masucci covers the Healthcare sector, focusing on stocks such as Castle Biosciences, Exagen, and Biodesix. According to TipRanks, Masucci has an average return of 10.2% and a 44.58% success rate on recommended stocks.
In a report released on September 11, B. Riley Securities also maintained a Buy rating on the stock with a $12.00 price target.